IpiNovyx Bio

IpiNovyx Bio is a biopharmaceutical company developing immunoproteasome-modulating therapeutics to treat autoimmune diseases.

IpiNovyx Bio operates in biopharma, biotechnology, health care, medical based in Greater New York Area, East Coast, Northeastern US, founded in 2021.

Its activity falls under biopharma, biotechnology, health care, medical; the profile below is assembled from public directory data.

Greater New York Area, East Coast, Northeastern US is where the company is located.

Its current recorded stage is Seed.

The company reports a headcount in the c_00001_00010 range.

Public records show total funding of about $10M.

Sector	Biopharma, Biotechnology, Health Care, Medical
Headquarters	Greater New York Area, East Coast, Northeastern US
Founded	2021
Employees	c_00001_00010
Stage	seed
Total funding	$10,000,000

Website: www.ipinovyxbio.com

Browse related